The gene patent dispute continues on both at home and abroad. Patents on genetic sequences have been a hotly contested part of United States patent law but we are not the only nation battling it out over isolated and purified sequences. Myriad Genetics recently came out victorious in an Australian court decision that recognized their ownership rights of gene linked to cancer. The victory was over Cancer Voices Australia and Yvonne D’Arcy, a Brisbane resident diagnosed with Breast cancer. “We intend to continue the challenge to the monopoly created by the patent held by Myriad,” Rebecca Gilsenan, a lawyer at Melbourne-based Maurice Blackburn, said in an e-mailed statement. Voice your opinion on this patent law issue below. And, as always, if you have any patent, trademark, copyright, or other intellectual property related questions, don’t hesitate to contact us at our Los Angeles or Beverly Hills Office by calling (310) 276-6664.
April 24, 2013